Trading Signals: CEMI Stock Price Prediction and Forecast (Wed. Nov. 26, 2003 - Wed. Jul. 21, 2021)(Chembio Diagnostics Inc)
| CEMI latest price $8.2000 (-1.91%) ($8.1400 - $8.7300) on Fri. Jun. 5, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 10.95% (three month average) | RSI | 27 | Latest Price | $8.2000(-1.91%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CEMI declines -3.2% a day on average for past five trading days. | Weekly Trend | CEMI declines -12.8% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support CEMI advance at 0% a week (0% probability) BNDX(49%) PCY(49%) VCIT(46%) CEMB(44%) LQD(43%) | Factors Impacting CEMI price | CEMI will decline at least -5.475% in a week (0% probabilities). URA(-32%) TBT(-31%) XME(-23%) VXX(-23%) PAVE(-18%) | | | | | Relative Volatility | | | | Market Trend Strength | -5.475% (StdDev 10.95%) | Hourly BBV | 0 () | Intraday Trend | -2.4% | | | |
|
1 - 5 Day Possible Target | $-13.94(-270%) | Resistance Level | $10.36 | 5 Day Moving Average | $8.67(-5.42%) | 10 Day Moving Average | $9.24(-11.26%) | 20 Day Moving Average | $10.36(-20.85%) | To recent high | -47.2% | To recent low | 60.2% | Market Cap | $165m | | | | Chembio Diagnostics, Inc. develops, manufactures, markets and licenses rapid point-of-care diagnostic tests that detect infectious diseases. The firm expanding its product portfolio based upon the proprietary Dual Path Platform, which uses a small drop of blood from the fingertip to provide cost-effective diagnostic results in approximately 15 minutes. Its products include human and veterinary diagnostics. The company was founded in 1985 and is headquartered in Hauppauge, NY. |